VEGFA and ischemia: Excessive ROS can also inhibit the expression of vascular endothelial growth factor (VEGF) and the formation of neovascularization after ischemia, thus decreasing the differentiation capacity of bone marrow-derived monocytes and endothelial progenitor cells [53].